KyDo Therapeutics
Dortmund, DE · 2 known investors
Find your way into KyDo Therapeutics
KyDo Therapeutics is a preclinical-stage biotechnology company developing novel covalent-allosteric small molecule inhibitors intended to become best-in-class oncology drugs. Its lead programs target hard-to-treat cancers such as glioblastoma, and the company is based in Dortmund, Germany.
Investors · 2
Frequently asked questions
- What does KyDo Therapeutics do?
- KyDo Therapeutics is a preclinical-stage biotechnology company developing novel covalent-allosteric small molecule inhibitors intended to become best-in-class oncology drugs. Its lead programs target hard-to-treat cancers such as glioblastoma, and the company is based in Dortmund, Germany.
- Who are KyDo Therapeutics's investors?
- KyDo Therapeutics's investors include i&i Biotech Fund, Khanu.
- Where is KyDo Therapeutics headquartered?
- KyDo Therapeutics is headquartered in Dortmund, DE.
